Table 3.
n Studies | n | Random IV, IC 95% | Test Overall Effects | Heterogeneity | ||||
---|---|---|---|---|---|---|---|---|
Participants | Effects | Z(p) | Tau2 | Chi2 | p | I 2 | ||
VO2max (mL/kg/min)-MD | ||||||||
CG | 16 | 234 | 0.03 [−0.55, 0.61] | 0.11 (0.91) | 0.000 | 13.88 | 0.530 | 0% |
CT | 28 | 367 | 2.93 [1.97, 3.90] | 5.98 (<0.001) | 4.010 | 114.31 | <0.001 | 76% |
MAS/MAP-MD | ||||||||
CG | 1 | 9 | 0.04 [−0.67, 0.75] | 0.11 (0.91) | N/A | N/A | N/A | N/A |
CT | 5 | 45 | 0.35 [0.02, 0.67] | 2.07 (0.04) | 0.000 | 3.73 | 0.440 | 0% |
Aerobic Performance-SMD | ||||||||
CG | 5 | 64 | −0.11 [−0.46, 0.24] | 0.63 (0.53) | 0.000 | 3.07 | 0.690 | 0% |
CT | 10 | 128 | 0.65 [0.09, 1.20] | 2.27 (0.02) | 0.620 | 39.82 | <0.001 | 77% |
VT2-SMD | ||||||||
CG | 3 | 32 | −0.01 [−0.50, 0.48] | 0.05 (0.96) | 0.000 | 0.01 | 0.990 | 0% |
CT | 5 | 57 | 0.20 [−0.29, 0.69] | 0.79 (0.43) | 0.120 | 6.63 | 0.160 | 40% |
CG = control group, CT = resistance circuit training, MD = mean differences, SMD = standardized mean difference, IV = inverse variance method, CI = confidence interval, VT2 = second ventilatory threshold, MAS-MAP = maximum aerobic speed/power.